- 2017 ACR/ARHP PRYSM Abstract Supplement (PDF)
- 2016 ACR/ARHP Abstract Supplement (PDF)
- 2015 ACR/ARHP Abstract Supplement (PDF)
- 2014 ACR/ARHP Abstract Supplement (PDF)
- 2013 ACR/ARHP Abstract Supplement (PDF)
- 2012 ACR/ARHP Abstract Supplement (PDF)
- 2011 ACR/ARHP Abstract Supplement (PDF)
- 2010 ACR/ARHP Abstract Supplement (PDF)
ACR Abstract Embargo Policy
Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until 4:30 PM Eastern Time on Saturday, November 12, 2016.
Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at firstname.lastname@example.org.
The annual meeting is a private event. Programs presented at the meeting are for the education of attendees and purchasers of recorded presentations as authorized by the American College of Rheumatology. The information and materials displayed and presented during this meeting are the property of the ACR and the presenter and cannot be photographed, copied, photocopied, transformed to electronic format, reproduced, or distributed without written permission of the American College of Rheumatology and the presenter. Any use of the program content for commercial purposes, which includes, but is not limited to oral presentations, audiovisual materials used by speakers, and program handouts without the written consent of the ACR is prohibited. This policy applies before, during and after the meeting. The ACR will enforce its intellectual property rights and penalize those who infringe upon it.
The names, insignias, logos and acronyms of the ACR, the ARHP and the Rheumatology Research Foundation are proprietary marks. Use of the names in any fashion, by any entity, for any purpose, is prohibited without the express written permission of the American College of Rheumatology. Attendees who have questions about the ACR’s copyright policy should contact the public relations department at email@example.com.